SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,314.59 -21.86
( -0.03%)

Global Indices

Nasdaq

51,493.09 -621.02
(-1.19%)

Dow Jones

7,573.47 -33.26
(-0.44%)

Hang Seng

63,960.24 37.24
(0.06%)

Nikkei 225

10,816.25 127.78
(1.20%)

Forex

USD-INR

95.42 0.14
(0.14%)

EUR-INR

110.10 0.01
(0.01%)

GBP-INR

128.62 0.03
(0.02%)

JPY-INR

0.62 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

163.1433353

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

FREDUN

45.46

2020.29

EPS(TTM)

Face Value()

Div & Yield %

26.87

0.02

Back

Gravita India consolidated net profit rises 14.08% in the June 2026 quarter

Jul 27,2026

Net profit of Gravita India rose 14.08% to Rs 106.39 crore in the quarter ended June 2026 as against Rs 93.26 crore during the previous quarter ended June 2025. Sales rose 41.84% to Rs 1475.06 crore in the quarter ended June 2026 as against Rs 1039.94 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1475.06	1039.94	42
OPM %	7.44	9.68	-
PBDT	145.77	124.64	17
PBT	131.28	115.93	13
NP	106.39	93.26	14

74,314.59 -21.86 ( -0.03%)

51,493.09 -621.02 (-1.19%)

7,573.47 -33.26 (-0.44%)

63,960.24 37.24 (0.06%)

10,816.25 127.78 (1.20%)

95.42 0.14 (0.14%)

110.10 0.01 (0.01%)

128.62 0.03 (0.02%)

0.62 0.00 (-0.26%)